Clinical trial
Pathogenicity of Enteroaggregative E. Coli in Adult Volunteers; Dose-Escalation Study
NCT00362869 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pathogenicity of Enteroaggregative E. Coli in Adult Volunteers; Dose-Escalation Study
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- February 29, 2008
- Completion date
- December 31, 2008
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.